These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 18178498

  • 1. Idiopathic short stature: management and growth hormone treatment.
    Wit JM, Reiter EO, Ross JL, Saenger PH, Savage MO, Rogol AD, Cohen P.
    Growth Horm IGF Res; 2008 Apr; 18(2):111-35. PubMed ID: 18178498
    [Abstract] [Full Text] [Related]

  • 2. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P, Reiter EO, KIGS International Board.
    Horm Res; 2007 Apr; 68(2):53-62. PubMed ID: 17228181
    [Abstract] [Full Text] [Related]

  • 3. Growth and growth hormone treatment in short stature children born small for gestational age.
    Labarta JI, Ruiz JA, Molina I, De Arriba A, Mayayo E, Longás AF.
    Pediatr Endocrinol Rev; 2009 Feb; 6 Suppl 3():350-7. PubMed ID: 19404234
    [Abstract] [Full Text] [Related]

  • 4. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect.
    Wit JM, Rekers-Mombarg LT, Cutler GB, Crowe B, Beck TJ, Roberts K, Gill A, Chaussain JL, Frisch H, Yturriaga R, Attanasio AF.
    J Pediatr; 2005 Jan; 146(1):45-53. PubMed ID: 15644821
    [Abstract] [Full Text] [Related]

  • 5. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study.
    Moore WV, Dana K, Frane J, Lippe B.
    Pediatr Endocrinol Rev; 2008 Sep; 6(1):5-8. PubMed ID: 18806719
    [Abstract] [Full Text] [Related]

  • 6. Optimal use of growth hormone therapy for maximizing adult height in children born small for gestational age.
    Simon D, Léger J, Carel JC.
    Best Pract Res Clin Endocrinol Metab; 2008 Jun; 22(3):525-37. PubMed ID: 18538291
    [Abstract] [Full Text] [Related]

  • 7. Growth hormone use in the treatment of idiopathic short stature.
    Zucchini S.
    Curr Opin Investig Drugs; 2008 Apr; 9(4):396-401. PubMed ID: 18393106
    [Abstract] [Full Text] [Related]

  • 8. Growth hormone treatment of idiopathic short stature: clinical studies.
    Hintz RL.
    Growth Horm IGF Res; 2005 Jul; 15 Suppl A():S6-8. PubMed ID: 16039887
    [Abstract] [Full Text] [Related]

  • 9. An auxology-based growth hormone program: update on the Australian experience.
    Werther GA, Wang M, Cowell CT.
    J Pediatr Endocrinol Metab; 2003 May; 16 Suppl 3():613-8. PubMed ID: 12795362
    [Abstract] [Full Text] [Related]

  • 10. Growth hormone therapy.
    Dash RJ, Muralidharan R, Talwar V.
    J Assoc Physicians India; 1999 Apr; 47(4):417-25. PubMed ID: 10778529
    [Abstract] [Full Text] [Related]

  • 11. Current prescribing practices and opinions about growth hormone therapy: results of a nationwide survey of paediatric endocrinologists.
    Hardin DS, Woo J, Butsch R, Huett B.
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):85-94. PubMed ID: 17201806
    [Abstract] [Full Text] [Related]

  • 12. Final height in Swedish children with idiopathic growth hormone deficiency enrolled in KIGS treated optimally with growth hormone.
    Westphal O, Lindberg A, Swedish KIGS National Board.
    Acta Paediatr; 2008 Dec; 97(12):1698-706. PubMed ID: 18976357
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of combined treatment with growth hormone and gonadotropin releasing hormone analogue in children with poor prognosis of adult height.
    Toumba M, Bacopoulou I, Savva SC, Skordis N.
    Indian Pediatr; 2007 Jul; 44(7):497-502. PubMed ID: 17684302
    [Abstract] [Full Text] [Related]

  • 14. Long-term results of treatment with low-dose fluoxymesterone in constitutional delay of growth and puberty and in genetic short stature.
    Strickland AL.
    Pediatrics; 1993 Apr; 91(4):716-20. PubMed ID: 8464656
    [Abstract] [Full Text] [Related]

  • 15. Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone.
    Rachmiel M, Rota V, Atenafu E, Daneman D, Hamilton J.
    Horm Res; 2007 Apr; 68(5):236-43. PubMed ID: 17396034
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone therapy and children with idiopathic short stature: a viable option?
    Willhaus J.
    Pediatr Nurs; 1999 Apr; 25(6):662-5. PubMed ID: 12024388
    [Abstract] [Full Text] [Related]

  • 17. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
    Blum WF, Cao D, Hesse V, Fricke-Otto S, Ross JL, Jones C, Quigley CA, Binder G.
    Horm Res; 2009 Apr; 71(3):167-72. PubMed ID: 19188742
    [Abstract] [Full Text] [Related]

  • 18. Auxological criteria for treating children with idiopathic short stature.
    Loche S.
    Horm Res Paediatr; 2011 Apr; 76 Suppl 3():16-18. PubMed ID: 21912151
    [Abstract] [Full Text] [Related]

  • 19. Management of short stature with GnRH agonist and co-treatment with growth hormone: a controversial issue.
    Carel JC.
    Mol Cell Endocrinol; 2006 Jul 25; 254-255():226-33. PubMed ID: 16787697
    [Abstract] [Full Text] [Related]

  • 20. [Constitutional delay of growth and puberty in male].
    Hirano T.
    Nihon Rinsho; 1997 Nov 25; 55(11):2952-7. PubMed ID: 9396294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.